Efficacy and Safety Evaluation of PD1-BCMA-CART
Condition(s):Multiple MyelomaLast Updated:January 5, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 5, 2024Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:May 17, 2022Withdrawn
Condition(s):Multiple MyelomaLast Updated:December 4, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:October 4, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:June 22, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:February 23, 2024Active, not recruiting
Condition(s):Relapsed/Refractory Multiple Myeloma(MM)Last Updated:March 15, 2024Terminated
Condition(s):Multiple MyelomaLast Updated:October 5, 2023Recruiting
Condition(s):Plasma Cell LeukemiaLast Updated:August 8, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:January 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.